Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer.

The Oncologist
Thomas DelateDeborah Schrag

Abstract

Evidence-based treatment guidelines recommend low molecular weight heparin (LMWH) monotherapy for cancer-associated venous thromboembolism (VTE). This analysis assessed the first-line treatment strategies for VTE in patients with advanced solid tumors. Using administrative data from advanced lung, prostate, colon, or breast cancer patients diagnosed between January 2000 and December 2007 at four HMOs with integrated delivery systems, patients with an inpatient or outpatient VTE diagnosed within 2 years after cancer diagnosis and an outpatient purchase of warfarin, LMWH, and/or fondaparinux anticoagulant within 7 days of the VTE diagnosis were identified. First-line outpatient VTE pharmacological treatment and factors independently associated with receipt/non-receipt of LMWH monotherapy were assessed. Overall, 25% of the 1,089 eligible patients received LMWH monotherapy as primary VTE treatment. The percentage increased steadily over time from 18% among patients diagnosed in 2000 to 31% among those diagnosed in 2007. Factors associated with LMWH monotherapy included VTE diagnosis year, chemotherapy within 60 days prior to VTE diagnosis, history of VTE prior to cancer diagnosis, and invasive surgery in the 90 days following VTE d...Continue Reading

References

Mar 23, 1991·BMJ : British Medical Journal·B LindbladD Bergqvist
Jul 1, 1996·Annals of Internal Medicine·P PrandoniM H Prins
Mar 13, 1999·Archives of Internal Medicine·P M KuijerH R Büller
Jun 5, 1999·Seminars in Thrombosis and Hemostasis·A Y Lee, M N Levine
Sep 30, 2000·Seminars in Thrombosis and Hemostasis·L R ZacharskiA C Mamourian
Dec 18, 2002·Annals of Internal Medicine·Paolo PrandoniAntonio Girolami
Feb 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giovanna MasciArmando Santoro
Jul 11, 2003·The New England Journal of Medicine·Agnes Y Y LeeUNKNOWN Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Veno
Nov 17, 2005·Journal of the National Cancer Institute. Monographs·Mark C HornbrookChristine Neslund Dudas
Sep 12, 2006·Journal of Thrombosis and Haemostasis : JTH·A K Wittkowsky
Jun 15, 2007·Joint Commission Journal on Quality and Patient Safety·Chunliu ZhanDavid Hunt
Oct 31, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary H LymanUNKNOWN American Society of Clinical Oncology
Mar 14, 2008·Journal of Thrombosis and Thrombolysis·Robin R HillDaniel M Witt
Feb 21, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Tienan ZhuJoseph Emmerich
May 15, 2010·Thrombosis Research·Michael B Streiff, UNKNOWN National Comprehensive Cancer Center Network
May 11, 2011·Circulation·Henri Bounameaux, Frits R Rosendaal
Jun 17, 2011·The Cochrane Database of Systematic Reviews·Elie A AklHolger Schünemann

❮ Previous
Next ❯

Citations

Apr 22, 2014·Journal des maladies vasculaires·M-A SevestreUNKNOWN Carmen Investigators for the Groupe Francophone Thrombose et Cancer (GFTC)
Feb 19, 2014·American Journal of Surgery·Dirk J BoschJohn Th M Plukker
Sep 5, 2012·Journal of Thrombosis and Haemostasis : JTH·D M Siegal, D Garcia
Mar 18, 2016·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·I MahéA Perozziello
Nov 7, 2015·Thrombosis·Sarah YentzBrandon McMahon
Jun 16, 2015·PloS One·Isabelle MahéUNKNOWN RIETE Investigators
Oct 21, 2016·Journal of Thrombosis and Haemostasis : JTH·I MahéS Noble
Nov 25, 2016·Thrombosis and Haemostasis·Cihan AyAlexander T Cohen
May 24, 2014·Clinical Medicine Insights. Oncology·Miguel Barbosa
Feb 5, 2019·Current Oncology Reports·Harsh K Patel, Alok A Khorana
Feb 6, 2018·American Journal of Hematology·Michael B StreiffAlok A Khorana
Aug 11, 2020·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Esin Aysel KandemirSaadettin Kilickap
Oct 2, 2017·The Cochrane Database of Systematic Reviews·Mina MohammadyAli Akbari Sari
Feb 9, 2019·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Alok A KhoranaJeff Schein
Nov 22, 2019·Current Treatment Options in Cardiovascular Medicine·Kristen M Sanfilippo, Tzu-Fei Wang
Nov 2, 2017·The Cochrane Database of Systematic Reviews·Mina MohammadyAli Akbari Sari
Aug 5, 2017·Current Medical Research and Opinion·Joanna B Eldredge, Alex C Spyropoulos
May 30, 2017·Research and Practice in Thrombosis and Haemostasis·Alok A KhoranaJeff Schein
Feb 6, 2021·Journal of Thrombosis and Thrombolysis·Jordan K SchaeferSuman L Sood
Nov 19, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·I García-EscobarUNKNOWN Cancer and Thrombosis Section of the Spanish Society of Medical Oncology (SEOM)
Jun 9, 2021·The Cochrane Database of Systematic Reviews·Mina MohammadyLeila Janani
Mar 29, 2019·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C AyI Pabinger
Dec 18, 2015·Journal of Health Economics and Outcomes Research·Joshua D BrownVal R Adams
Oct 2, 2017·Journal De Médecine Vasculaire·I MahéUNKNOWN AFSOS (French-speaking Association for Supportive Care in Oncology), SFMV (French Society for Vascular Medicine)

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.